Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CEMI | ABT | SYK | MDT | BSX |
| Company | Chembio Diagnostics | Abbott Laboratories | Stryker Corp | Medtronic Inc | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 0.4500 | 105.93 | 333.58 | 79.99 | 71.61 |
| High | 0.4550 | 107.16 | 335.73 | 81.73 | 72.99 |
| Low | 0.4470 | 105.91 | 320.72 | 79.99 | 71.14 |
| Last | 0.4550 | 106.29 | 328.12 | 80.89 | 72.21 |
| Change | +0.0010 | +0.32 | -8.38 | +0.65 | +0.34 |
| % Change | +0.22% | +0.30% | -2.49% | +0.81% | +0.47% |
| Volume | 351,600 | 4,097,100 | 2,766,900 | 5,366,100 | 6,021,000 |
| 20-Day Average Volume | 480,165 | 5,375,205 | 1,367,170 | 6,101,695 | 7,152,520 |
| Previous Close | 0.4540 | 105.97 | 336.50 | 80.24 | 71.87 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4485 | 108.40 | 338.81 | 81.01 | 69.52 |
| 20-Day Raw Stochastic | 77.59% | 24.52% | 21.86% | 35.29% | 71.28% |
| 20-Day Relative Strength | 57.39% | 39.10% | 38.89% | 45.40% | 65.27% |
| Weighted Alpha | -41.94 | -3.60 | +15.76 | -8.16 | +46.95 |
| Today's Opinion | 72% Buy | 24% Sell | 24% Buy | 40% Sell | 100% Buy |
| Previous Opinion | 56% Buy | 24% Sell | 40% Buy | 56% Sell | 100% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 88% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.11% since 04/20/23 | -0.56% since 04/24/24 | -2.59% since 04/24/24 | +0.63% since 04/24/24 | -0.96% since 04/24/24 |
| Low | 0.4470 on 04/27/23 | 105.89 on 04/30/24 | 320.71 on 05/01/24 | 78.78 on 04/25/24 | 71.14 on 05/01/24 |
| High | 0.4620 on 04/25/23 | 108.19 on 04/29/24 | 340.42 on 04/29/24 | 81.73 on 05/01/24 | 73.64 on 04/25/24 |
| 1-Month | |||||
| %Chg | +30.00% since 03/27/23 | -5.17% since 04/01/24 | -7.49% since 04/01/24 | -7.04% since 04/01/24 | +6.04% since 04/01/24 |
| Low | 0.3540 on 03/28/23 | 104.25 on 04/17/24 | 320.71 on 05/01/24 | 78.43 on 04/18/24 | 66.80 on 04/22/24 |
| High | 0.4680 on 04/17/23 | 112.57 on 04/09/24 | 354.88 on 04/03/24 | 86.91 on 04/02/24 | 74.39 on 04/24/24 |
| 3-Month | |||||
| %Chg | +29.96% since 01/27/23 | -7.16% since 02/01/24 | -3.65% since 02/01/24 | -8.17% since 02/01/24 | +11.40% since 02/01/24 |
| Low | 0.3200 on 03/16/23 | 104.25 on 04/17/24 | 320.71 on 05/01/24 | 78.43 on 04/18/24 | 64.08 on 02/06/24 |
| High | 0.4680 on 04/17/23 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 88.25 on 02/07/24 | 74.39 on 04/24/24 |
| 6-Month | |||||
| %Chg | +38.30% since 10/27/22 | +11.87% since 11/01/23 | +20.61% since 11/01/23 | +14.17% since 11/01/23 | +39.78% since 11/01/23 |
| Low | 0.1900 on 12/29/22 | 92.43 on 11/10/23 | 266.93 on 11/10/23 | 69.32 on 11/10/23 | 50.84 on 11/10/23 |
| High | 0.4680 on 04/17/23 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 89.18 on 01/31/24 | 74.39 on 04/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,710 | 183,877,440 | 128,028,160 | 106,544,512 | 107,805,000 |
| Shares Outstanding, K | 36,726 | 1,735,184 | 380,470 | 1,327,823 | 1,500,000 |
| Annual Sales | 49,520,000 | 40,109,000,000 | 20,498,000,000 | 31,227,000,000 | 14,240,000,000 |
| Annual Net Income | -23,290,000 | 5,723,000,000 | 3,165,000,000 | 3,758,000,000 | 1,591,000,000 |
| Last Quarter Sales | 10,340,000 | 9,964,000,000 | 5,815,000,000 | 8,089,000,000 | 3,856,000,000 |
| Last Quarter Net Income | -860,000 | 1,225,000,000 | 1,143,000,000 | 1,322,000,000 | 492,000,000 |
| 60-Month Beta | 1.85 | 0.74 | 0.89 | 0.76 | 0.78 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/03/22 | 0.98 on 04/17/24 | 3.46 on 01/30/24 | 1.30 on 02/20/24 | 0.56 on 04/24/24 |
| Latest Earnings Date | 05/04/23 | 04/17/24 | 04/30/24 | 05/23/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.550 on 04/12/24 | 0.800 on 03/27/24 | 0.690 on 03/21/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/12/24 | 03/27/24 | 03/21/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.44 | 31.97 | 15.20 | 33.88 |